Ethionamide is an anti-tuberculosis drug and is used with other medicines to treat tuberculosis. Ethionamide works by stopping the growth of bacteria, and it works for bacterial infections, and not for viral infections.

Isoniazid medicine 150mg is made in the form of tablets, the main ingredient is Isoniazid. The drug is used in the prevention and treatment of pulmonary tuberculosis and extrapulmonary tuberculosis.

Pyrazinamide drug is currently known quite popularly with the main effect is to treat bacterial infections of pulmonary tuberculosis. The drug is widely available in all pharmacies nationwide with the form of Pyrazinamide 500mg and Pyrazinamide 400mg.

Drug-resistant tuberculosis is a public health crisis and a global health security threat with serious consequences for those affected. Treatment of drug-resistant or rifampicin-resistant tuberculosis requires a combination of different second-line drugs and a treatment duration of 18 months or more.

The main cause of drug-resistant tuberculosis is patient non-compliance with treatment regimens. Currently, Vietnam is one of 30 countries with a high burden of drug-resistant tuberculosis in the world. Although there have been some significant achievements in the prevention of tuberculosis in general and drug-resistant tuberculosis in particular, drug-resistant tuberculosis remains a global concern.

Combining vitamin C with anti-tuberculosis drugs may shorten treatment time. The results, obtained in mice and tissue cultures in the laboratory, have opened a new direction to solve the difficult problem of treating multidrug-resistant tuberculosis.